InflaRx N.V. IFRX
1.48 USD -0.14 (-8.64%)
At closeNov 4, 2026, 4:20 PM EST
1.48 0.00 0.00%
After hours · Nov 4, 4:20 PM ET
1.33 Day range 1.72
0.798 52-week range 2.95
- YTD
- +46.53%
- 1 year
- +16.54%
Analyst view
Consensus: buy
Buy
Price target (mean) 8.09 +446.6% upside
Now 1.48
- Target (low)
- 4.93
- Target (mean)
- 8.09
- Target (high)
- 12.61
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy1
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.28 | -0.29 – -0.26 | -0.28 | 0.0% | 133.33K | +5722.3% | 3 |
| Next quarter | -0.305 | -0.35 – -0.26 | -0.17 | -79.4% | 47.00K | +30.4% | 2 |
| Current year | -0.98 | -0.99 – -0.96 | -0.78 | -25.6% | 311.00K | +392.9% | 3 |
| Next year | -1.09 | -1.22 – -0.95 | -0.98 | -10.9% | 571.00K | +83.6% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 25, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 2, 2023 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Sep 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 31, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2023 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Apr 21, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 6, 2023 | Raymond James | Maintained | — | Strong Buy |
| Apr 5, 2023 | Guggenheim | Upgrade | Neutral | Buy |
| Apr 5, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 5, 2023 | LifeSci Capital | Upgrade | Market Perform | Outperform |
| Mar 23, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 6, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 10, 2022 | Raymond James | Maintained | — | Strong Buy |
| Aug 8, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 13, 2022 | Credit Suisse | Maintained | — | Underperform |
| May 13, 2022 | Raymond James | Maintained | — | Strong Buy |
| May 13, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 12, 2022 | SVB Leerink | Maintained | — | Outperform |
| Mar 25, 2022 | SVB Leerink | Maintained | — | Outperform |
| Nov 8, 2021 | Raymond James | Maintained | — | Strong Buy |